Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025BMC UrologyOpen Access

Proteinuria reduction by and safety of finerenone in Chinese patients with CKD without diabetes: a real-world retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

TCTing CongYQYue QinXWXingzhi Wang

Discussion

Loading...

Member takes

Overview

Retrospective study shows finerenone significantly reduces proteinuria in CKD patients, suggesting safety and effectiveness.

Key Points

  • Finerenone treatment significantly reduced proteinuria levels after 5 months, indicating its effectiveness in CKD management.
  • Patients experienced a median proteinuria reduction of 2.46 g, with an impressive percentage change of 60.86%.
  • No significant changes occurred in estimated glomerular filtration rate or serum potassium, supporting the safety of finerenone.
  • The study involved 43 patients with a mean age of about 51; membranous nephropathy was present in 20 of them.

Cite This Study

Cong et al. (2025) studied this question.

synapsesocial.com/papers/68c23fc3b210217d64797406https://doi.org/10.1186/s12894-025-01897-2
View Full Paper
Ask AI
Bookmark
Share